LIMA (Reuters) – Peru’s interim president said on Thursday his administration had locked in a deal with Pfizer to purchase 20 million doses of its coronavirus vaccine, a major milestone as the Andean nation scrambles to jumpstart a mass vaccination program.
The South American country earlier this week approved Pfizer’s COVID-19 vaccine – co-developed with German partner BioNTech – for one year amid a recent spike in coronavirus cases that has brought local hospitals to the brink of collapse.
(Reporting by Marco Aquino, writing by Dave Sherwood; Editing by Chizu Nomiyama)
